Dr. Rosen's research primarily focuses on conditions affecting young cancer survivors, including evaluating programs that enhance healthcare providers' knowledge and confidence in treating these patients. He also studies the mental health impacts of trauma in displaced populations, such as those in conflict zones like Yemen. Furthermore, his work on genetic factors related to obsessive-compulsive disorder and chronic tic disorders helps identify new treatment avenues. By integrating advanced technologies and methods, he explores innovative solutions to complex health issues, highlighting the role of personalized care in managing chronic diseases like scleroderma.
Key findings
Healthcare professionals' knowledge scores increased from 2.8 to 3.5 after participating in a cancer support training program.
In Yemen, trauma exposure was rated at 2.95, and post-traumatic stress symptoms at 2.80, emphasizing a critical need for mental health support.
The combination of capivasertib and trastuzumab deruxtecan showed enhanced tumor-fighting effects compared to standard treatment, increasing cell death in sensitive cancer types.
In a study of children with juvenile idiopathic arthritis, 49% had jaw issues at the beginning, which decreased to 38% after two years, highlighting the need for monitoring.
The AI model in liver evaluations achieved 96.4% accuracy in identifying significant fat content, surpassing human pathologists' accuracy.
Frequently asked questions
Does Dr. Rosen study cancer in children?
Yes, Dr. Rosen focuses on improving care for pediatric, adolescent, and young adult cancer survivors.
What type of mental health issues does Dr. Rosen research?
He studies trauma and post-traumatic stress symptoms in populations displaced by conflict, particularly in regions like Yemen.
Has Dr. Rosen done research on genetic disorders?
Yes, he has investigated genetic factors linked to obsessive-compulsive disorder and chronic tic disorders, identifying key genes that impact these conditions.
What advancements has Dr. Rosen contributed to cancer treatment?
He has researched new drug combinations that enhance the effectiveness of existing treatments for HER2-positive and HER2-low cancers.
How does Dr. Rosen's work assist healthcare providers?
His research develops tools and methods that improve the diagnostic accuracy and treatment strategies used by healthcare professionals, benefiting both patients and providers.
Publications in plain English
Development of a Personalized Visualization and Analysis Tool to Improve Clinical Care in Complex Multisystem Diseases With Application to Scleroderma.
2026
Arthritis care & research
Kim JS, Scott J, Fisher L, Smith LN, Stewart W +14 more
Plain English Researchers created a new digital tool to help doctors and patients understand scleroderma, a complex disease that affects multiple organs. Testing showed that patients who used the tool felt more informed and confident about their health, while doctors could access data much faster—up to 8.6 times more information in less time. This tool is important because it helps improve medical decision-making by providing a clear view of a patient’s health risks and progress.
Who this helps: This benefits patients with scleroderma and their doctors.
Magnetic Resonance Imaging-Based Cohesive Extended Finite Element Modeling of Atypical Femoral Fracture.
2026
Journal of biomechanical engineering
Sedigh A, Kamona N, Jones BC, Vu BT, Friday C +5 more
Plain English This study looked at a rare type of leg fracture called atypical femoral fracture (AFF) that can happen in people taking a certain medication for osteoporosis. Researchers used advanced MRI technology to examine how the shape and materials of the thigh bone affect the risk of these fractures. They found that specific bone shapes and better material properties from MRI scans increase the bone's strength, which is important for understanding what makes these fractures more likely to happen.
Who this helps: This helps patients at risk of atypical femoral fractures and their doctors in assessing and preventing these injuries.
Temporomandibular disorder in children with juvenile idiopathic arthritis with and without temporomandibular joint involvement compared to controls - a two-year prospective multicenter cohort study.
2026
BMC oral health
Halbig JM, Stoustrup P, Kristensen KD, Frid P, Rypdal V +15 more
Plain English This study looked at jaw pain and related symptoms in children with juvenile idiopathic arthritis (JIA) compared to children without JIA over two years. It found that almost half (49%) of children with JIA and jaw joint involvement had at least one jaw issue at the beginning, which went down to 38% after two years, while only 5% of the control group had these problems. The study also revealed that children with more active JIA had a much higher chance of experiencing jaw pain.
Who this helps: This helps pediatric rheumatologists and dentists who treat children with JIA by informing them to closely monitor these patients for jaw-related issues.
Evaluating the performance of multiphasic CT in assessing biliary tumor extent and resectability in perihilar cholangiocarcinoma: insights from a Western population.
2026
Abdominal radiology (New York)
Kim TH, Law W, El Homsi M, Argiriadi P, Rosen A +5 more
Plain English This study looked at how well a special type of CT scan, called multiphasic CT, works for assessing the size and operability of bile duct tumors in patients with a specific type of cancer known as perihilar cholangiocarcinoma. Researchers found that the CT scans had high accuracy in correctly identifying the presence of tumors (65-97% specific) but generally low sensitivity, meaning they missed some tumors (0-80% sensitive). Improving the quality of CT scans and using structured reporting can help doctors better plan surgeries for these patients.
Who this helps: This benefits patients facing surgery for bile duct cancer and their doctors.
Parallel course of calcinosis and cancer in a patient with anti-NXP2-positive dermatomyositis: A case report.
2026
Modern rheumatology case reports
Mecoli CA, Viswanathan AN, Rosen A, Casciola-Rosen L
Plain English This study examines the case of a 46-year-old woman with dermatomyositis who developed significant calcinosis and cervical cancer at the same time after five years of her illness. After aggressive treatment for both conditions, her cancer went into remission, and her symptoms improved, indicating that the calcinosis and cancer may be connected and influence each other. Understanding this relationship is important for improving treatment strategies for patients facing both conditions.
Who this helps: This helps patients with dermatomyositis and their doctors in managing complex cases involving cancer.
Trauma and post-traumatic stress symptoms among internally displaced populations in Yemen: evidence from a mixed-methods study.
2026
Conflict and health
Aldbyani A, Rosen A, Salem A, Almansoub HAMM
Plain English This study looked at the mental health of people who have been displaced by conflict in Yemen, specifically focusing on their experiences of trauma and symptoms of post-traumatic stress. Researchers found that these individuals have a moderate to high level of trauma exposure and significant symptoms of post-traumatic stress, with average scores showing issues in both areas (a trauma score of 2.95 and a PTSD score of 2.80). The findings highlight the critical need for effective mental health support for these populations, addressing both their individual needs and the broader challenges they face.
Who this helps: This helps displaced individuals in Yemen, mental health professionals, and organizations providing support in conflict zones.
Building Workforce Capacity in Pediatric, Adolescent, and Young Adult Cancer Survivorship: Evaluation of a National Project ECHOProgram.
2026
Journal of adolescent and young adult oncology
McBride J, Rosen A, Peairs K, Roth M, Kadan-Lottick N +1 more
Plain English This study examined a program called ECHO that aimed to improve health care professionals' knowledge and confidence in caring for kids and young adults who have survived cancer. After participating in 12 sessions, professionals’ knowledge scores increased from 2.8 to 3.5, and their confidence scores rose from 2.7 to 3.4. This improvement is important because it means that more health care providers are better prepared to support the unique needs of young cancer survivors.
Who this helps: This benefits patients, particularly pediatric, adolescent, and young adult cancer survivors and their families.
Capivasertib combines with trastuzumab deruxtecan to enhance anti-tumour activity in HER2-positive and HER2-low tumours.
2026
Molecular cancer therapeutics
Bashi AC, Proia TA, Lawson M, Nelson A, Ireland L +6 more
Plain English This study looked at how two cancer treatments, capivasertib and trastuzumab deruxtecan (T-DXd), work together to fight certain types of breast and other cancers that have HER2 proteins. Researchers found that combining these two treatments led to better anti-tumor effects in both HER2-positive and HER2-low cancer models, achieving significant tumor reduction in tests, even when the PI3K-AKT pathway was not altered. This matters because it shows a promising new treatment approach that could help more patients with various HER2-related cancers.
Who this helps: Patients with HER2-positive and HER2-low breast cancer and other related tumors.
Insights From Diverse Perspectives on Social Media Messages to Inform Young Adults With Cancer About Clinical Trials: Focus Group Study.
2025
JMIR formative research
Beauchemin MP, Walker D, Rosen A, Frazer M, Eisenberger M +5 more
Plain English This study explored the challenges young adults aged 15 to 39 face when considering participation in clinical trials for cancer treatments. Researchers held focus groups with diverse young patients across the U.S. and identified key barriers, such as a lack of accessible information, financial concerns, and fear of the unknown, as well as the need for a supportive network. The findings highlight the importance of using digital technology and social media to provide reliable information that can help increase clinical trial participation, which is crucial for improving cancer treatment options and outcomes for this age group.
Who this helps: This helps young adults with cancer and their healthcare providers.
Precise identification and tracking of HMGCR-reactive CD4+ T cells in the target tissue of patients with anti-HMGCR immune-mediated necrotising myopathy.
2025
Annals of the rheumatic diseases
Tiniakou E, Girgis A, Siafei T, Albayda J, Adler B +9 more
Plain English This study focused on a specific type of muscle disease known as anti-HMGCR immune-mediated necrotising myopathy (IMNM), which is linked to certain autoantibodies and genes. Researchers found that patients with anti-HMGCR+IMNM had significantly higher levels of immune cells (CD4+ T cells) that react to the HMGCR protein in their muscle tissue compared to patients with a related condition (dermatomyositis) – 90% of IMNM patients responded to HMGCR peptides, while only 10% of those with dermatomyositis did. This research helps to pinpoint the role of these immune cells in the disease, which could lead to better-targeted treatments.
Who this helps: This benefits patients suffering from anti-HMGCR immune-mediated necrotising myopathy and their doctors.
Boarding in the Emergency Department: Specific Harms to Older Adults and Strategies for Risk Mitigation.
2025
Emergency medicine clinics of North America
Joseph JW, Rosen A, Kennedy M
Plain English This study looked at the negative effects of keeping older adults in the emergency department (ED) for too long while they wait for a hospital bed. It found that older patients are more likely to experience serious problems like confusion and delirium when they are boarded in the ED, leading to poorer care overall. By prioritizing these at-risk older patients for admission, hospitals can improve their care and potentially shorten their time in the hospital.
Who this helps: This helps older patients who are often more vulnerable when stuck in emergency departments.
Benefits, limitations, and impacts of reproductive carrier screening and telehealth-based genetic counseling for individuals with an increased chance to have a child with a genetic condition.
2025
Journal of genetic counseling
Hardy MW, Bruder K, Rosen A, Ali N, Laney D +4 more
Plain English This study looked at how individuals and couples who might have a higher chance of having a child with a genetic condition were affected by a screening program and genetic counseling offered online by JScreen. Out of over 1,000 people surveyed, 290 responded, showing that 54.1% of couples considering their reproductive options after getting results chose to explore alternative plans. The findings highlight that patients felt satisfied with the online counseling and found the information useful in making important decisions about their future children.
Who this helps: This helps patients and couples facing genetic risks in family planning.
Cytokines in saliva, serum, and temporomandibular joint synovial fluid in children with juvenile idiopathic arthritis: An explorative cross-sectional study.
2025
Pediatric rheumatology online journal
Frid P, Halbig JM, Alstergren P, Berstad JR, Cetrelli L +10 more
Plain English This study looked at specific proteins called cytokines in saliva, blood, and joint fluid from children with juvenile idiopathic arthritis (JIA) and compared them to children without this condition. Researchers found that children with JIA had higher levels of multiple cytokines in their saliva, while no differences were noted in their blood samples. This is important because it suggests that saliva might be a useful way to monitor inflammation in children with JIA.
Who this helps: This helps patients with juvenile idiopathic arthritis by providing insights for better monitoring and treatment.
Pregnancy outcomes following medical vs surgical treatment of tubal ectopic pregnancy: a population-based retrospective cohort study.
2025
American journal of obstetrics and gynecology
Rosen A, Palma L, Ordon M, Melamed N, Saskin R +3 more
Plain English This study looked at how well patients do after being treated for tubal ectopic pregnancy, comparing those who received medical treatment with methotrexate to those who had surgery. It found that 51.6% of patients treated with methotrexate subsequently had a live birth, compared to 45.1% for those who had surgery, but there was a slightly higher chance of needing further treatment for a recurring ectopic pregnancy in the medical group (7.4% vs. 6.4%). Understanding these outcomes helps patients and doctors make better choices about the safest and most effective treatment options.
Who this helps: Patients dealing with tubal ectopic pregnancy and their healthcare providers.
Healthcare accessibility in Yemen's conflict zones: comprehensive review focused on strategies and solutions.
2025
Conflict and health
Salem A, Rosen A, Alharazi I, Gamallat Y, Aldbyani A +2 more
Plain English This study explored how the ongoing conflict in Yemen has made it extremely difficult for people to access healthcare. It found that the war has severely damaged medical facilities and created shortages of supplies, making it hard for communities to get even basic medical services. The authors recommend urgent solutions like rebuilding healthcare infrastructure, ensuring steady supplies of medical resources, and providing training programs for healthcare workers to improve the situation.
Who this helps: This helps patients in Yemen, especially those living in conflict zones.
The Natural History Study and Biomarker Collection of the Clinical Research Consortium for the Study of Cerebellar Ataxia (CRC-SCA).
2025
Cerebellum (London, England)
Lin Y, Amokrane N, Worley S, Moore LR, Rosen A +41 more
Plain English This study looked at hereditary ataxias, which are disorders that damage the brain and affect movement, specifically focusing on spinocerebellar ataxias (SCAs). Researchers tracked disease progression and collected samples like blood and spinal fluid to find biological markers that can measure how the disease is moving forward or responding to treatments. Their work has developed new assessment tools to better understand these conditions and improve clinical trials, paving the way for new therapies.
Who this helps: This benefits patients with hereditary ataxias and their doctors by providing better ways to track disease progression and treatment effects.
Novel Pretreatment Autoantibodies Correlate with Enfortumab Vedotin-Related Dermatologic Events in Patients with Advanced Urothelial Cancer.
2025
Cancer research communications
Vlachou E, Johnson BA, McConkey DJ, Hahn NM, Jing Y +5 more
Plain English This study looked at whether certain pre-existing autoantibodies in patients with advanced bladder cancer could predict skin reactions related to the treatment with enfortumab vedotin (EV), especially when combined with another drug, pembrolizumab. The researchers found that out of 23 patients, 6 had these autoantibodies, and all of them experienced skin issues during the treatment. This is important because understanding these autoantibodies could help identify patients at risk for these skin reactions, which are linked to better treatment outcomes.
Who this helps: Patients with advanced bladder cancer receiving enfortumab vedotin treatment.
Fragmentation signatures in cancer patients resemble those of patients with vascular or autoimmune diseases.
2025
Proceedings of the National Academy of Sciences of the United States of America
Curtis SD, Liu T, Bai Y, Wang Y, Panda S +28 more
Plain English This study looked at the patterns of cell-free DNA fragments in the blood of cancer patients compared to those with other diseases like blood clots and autoimmune disorders. The researchers found that patients with conditions such as systemic lupus erythematosus and venous thromboembolism had DNA fragmentation patterns similar to those in advanced cancer patients, which could lead to misdiagnosis. By combining these fragmentation patterns with other blood markers, they created a new method that could more accurately detect cancer in patients with these other conditions.
Who this helps: This helps patients with autoimmune or vascular diseases who may be misdiagnosed with cancer.
Parent-Child Interaction Therapy's Influence on Parental Behavior and Child Compliance in a Child-Welfare Involved Randomized Clinical Trial.
2025
Child & family behavior therapy
Rosen A, Kwasneski K, Liao X, Bard D, Skowron E
Plain English The study looked at how different ways parents talk to their children affect how well the kids follow instructions, especially in families at risk of abuse or neglect. Researchers found that giving direct commands and using positive comments helped children comply better, while too many commands reduced compliance. Interestingly, the longer the time since a parent said something negative, the more likely it was that the child would comply afterward. This is important because it shows that specific parenting techniques can improve child behavior in at-risk families.
Who this helps: Parents and caregivers in at-risk families.
Pathogenic UNC13A variants cause a neurodevelopmental syndrome by impairing synaptic function.
2025
Nature genetics
Asadollahi R, Ahmad A, Boonsawat P, Shahanoor Hinzen J, Lohse M +145 more
Plain English This study focused on the UNC13A gene, which is important for how neurons communicate. Researchers found that certain changes in this gene can lead to a range of serious issues, including developmental delay and intellectual disabilities, seizures, and even death in early childhood. They identified three major ways these genetic changes harm neuron function, emphasizing that proper communication between neurons is crucial for brain health.
Who this helps: This information benefits patients with neurodevelopmental issues and their families, as well as doctors diagnosing and treating these conditions.
Review of Large Language Models for Patient and Caregiver Support in Cancer Care Delivery.
2025
JCO clinical cancer informatics
Kouzy R, Cha EE, Rosen A, Bitterman DS
Plain English This study looked at how large language models (LLMs), which are advanced computer programs, can help support cancer patients and their caregivers. It found that these models show good accuracy for providing basic cancer information but struggle with more complicated medical scenarios. Overall, while there's promise in using LLMs to improve education and patient support, challenges like privacy, equitable access, and accuracy still need to be addressed.
Who this helps: Patients and caregivers dealing with cancer.
Rare coding mutations identify 36 large-effect risk genes in obsessive-compulsive disorder and chronic tic disorders.
2025
medRxiv : the preprint server for health sciences
Wang B, Tran MN, Wang S, Liu Y, Olfson E +60 more
Plain English Researchers studied the genetic factors behind obsessive-compulsive disorder (OCD) and chronic tic disorders (CTD) by examining the DNA of nearly 4,000 individuals. They discovered 36 important genes that are linked to a higher risk for these disorders, with some showing significant mutations that could greatly influence the conditions. This finding is crucial because it not only helps us understand the roots of OCD and CTD better but also points to potential new treatments.
Who this helps: This helps patients with OCD and CTD, as well as their doctors.
Accuracy of Foundation Artificial Intelligence Models for Hepatic Macrovesicular Steatosis Quantification in Frozen Sections.
2025
Archives of pathology & laboratory medicine
Koga S, Guda A, Wang Y, Sahni A, Wu J +10 more
Plain English This study looked at how well two artificial intelligence (AI) models, Prov-GigaPath and UNI, could analyze liver biopsy samples from donors to identify fat accumulation, which is important for making liver transplant decisions. In tests with 131 samples, the Prov-GigaPath model was 96.4% accurate in determining whether the fat content was clinically significant (<30% fat), while the other model and human pathologists had slightly lower accuracies of 85.7% and 89.3%, respectively. This is important because using AI could help make liver evaluations more consistent and reliable during surgeries.
Who this helps: This research benefits doctors and healthcare providers involved in liver transplantation.
Diagnosis and management of persistent post-operative pain following temporomandibular joint surgery: a survey-based study of oral and maxillofacial surgeons.
2025
The British journal of oral & maxillofacial surgery
Bavarian R, Etwaru K, Suri D, Handa S, Rosen A +2 more
Plain English This study examined how oral and maxillofacial surgeons handle ongoing pain that some patients experience after temporomandibular joint (TMJ) surgery. Out of 130 surveyed surgeons, only 30% discussed the risk of chronic pain with their patients, and just 14 referred those with ongoing pain to pain specialists, showing a gap in care. Recognizing and addressing these issues is crucial because better management of post-surgery pain can significantly improve patient recovery and quality of life.
Who this helps: This benefits patients recovering from TMJ surgery.
How much is too much? A medication use evaluation of VA ICU sedation practice during the COVID-19 pandemic.
2025
PloS one
Murphy IC, Bryan K, Burk M, Jiang R, Cunningham F +21 more
Plain English Researchers studied how medication use for sedation in critically ill Veterans changed during the COVID-19 pandemic compared to before. They found that sedative doses, particularly fentanyl, increased significantly for COVID-positive patients, with a median dose rising from 1,575 mcg before the pandemic to 2,688 mcg during the first two years, and mortality rates were also higher (26.9% pre-COVID vs. 36.8% during Year 1). These changes suggest that sedation practices may need to be adjusted to ensure patient safety during future health crises.
Who this helps: This research benefits doctors and hospital staff treating critically ill patients.
Dynamic proportional loss of functional connectivity revealed change of left superior frontal gyrus in subjective cognitive decline: an explanatory study based on Chinese and Western cohorts.
2025
GeroScience
Wang L, Hu W, Dong F, Sheng C, Wu J +306 more
Plain English This study analyzed brain scans from people with subjective cognitive decline (SCD) to understand early changes in brain function, especially in a specific area called the left superior frontal gyrus (SFG). Researchers found that a measurement called dynamic proportional loss of functional connectivity (DPLFC) in the left SFG decreased more significantly in individuals as their risk for Alzheimer's disease increased. This matters because identifying DPLFC could help diagnose SCD earlier and more accurately, potentially leading to better management of cognitive decline.
Who this helps: This helps patients at risk for Alzheimer's and their doctors.